Global Tamoxifen Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027Price: 3600/- USD | Published Date: September 9, 2020 |
The global tamoxifen market has been projected to grow at the CAGR of 0.6% market during 2020-2027. Tamoxifen is among the oldest and most prescribed antagonist of the estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is an approved drug for metastatic hormone-receptor-positive breast cancer, and to reduce the risk of recurrence after surgery and chemotherapy. Women at a high risk of developing breast cancer are also advised to take tamoxifen. Other uses of tamoxifen include treatment of ductal carcinoma, McCune-Albright syndrome, Gynecomastia, Infertility, and Riedel’s Thyroiditis. Efficacy of hormone therapy for management and treatment of breast cancer across the different stages of treatment and extensive use of tamoxifen as adjuvant therapy is the key factors driving the demand of the tamoxifen market. However, the growth of tamoxifen-resistant cancer and the introduction of a drug inducing endometrial cancer may act as a market growth barrier during the forecast period.
Currently, North America held the pole position in the global tamoxifen market and shall dominate the market throughout the forecast period. Large patient base of breast cancer, growing awareness regarding cancer screening and prevention, well-organized healthcare infrastructure, and reimbursement scenario are the factors assisting the growth of the tamoxifen market in North America. Asia-Pacific is expected to experience the fastest growth during the forecast period. High incidence of late stage breast cancer in the regions and rapid development of healthcare infrastructure are the prime drivers of the growth of the tamoxifen market in Asia-Pacific.
Market Segment Insights:
The global tamoxifen market for the purpose of this study is studied for applications. The major application of tamoxifen is in the treatment of metastatic hormone-receptor-positive breast cancer. However, the application of tamoxifen is growing in the treatment of conditions such as McCune-Albright syndrome, infertility, gynecomastia, bipolar disorder, angiogenesis and Riedel’s thyroiditis, and its use in research studies involving gene expression serve as future avenues for the growth of this market.
Global Tamoxifen Market Segmentation:
By Application, 2018–2027 ($ Million)
- Breast Cancer
- McCune-Albright syndrome
- Others (Infertility, Gene Expression, Riedel’s Thyroiditis)
By Geography, 2018-2027 ($ Million)
- North America
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
For the purpose of this study, the global tamoxifen market is regionally categorized into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa markets. These regional markets are further sub-segmented into top country level markets that majorly determine the regional industry trends. Among the considered regional markets, North America currently dominates the global tamoxifen market, with the U.S. being the largest county-level market due to large patient pool of breast cancer, growing awareness regarding cancer screening, well managed healthcare infrastructure and reimbursement scenario are the factors assisting the growth of tamoxifen market in North America. Asia-Pacific is expected to experience the fastest growth during the forecast period owing to the factors such as high incidence of late stage breast cancer in the regions and rapid development of healthcare infrastructure leading to the growth of tamoxifen market in Asia-Pacific.
Market Competition Assessment:
The major players currently operating in the global tamoxifen market include AstraZeneca plc, Allergan plc, Teva Pharmaceuticals Industries Ltd., Apotex, Inc., Mylan Pharmaceuticals, Inc., Watson laboratories Inc., and Aegis pharmaceuticals Inc.
List of Key Companies:
- AstraZeneca plc
- Allergan plc
- Teva Pharmaceuticals Industries Ltd.
- Apotex, Inc.
- Mylan Pharmaceuticals, Inc.
- Watson laboratories Inc.
- Aegis pharmaceuticals Inc.
Request a free report sample @ https://www.researchcorridor.com/request-sample/?id=12260
Table of Content:
1.1. Report Scope and Description
1.2. Research Methodology
2. Executive Summary
2.1. Global Tamoxifen Market Snapshot
2.2. Global Tamoxifen Market, by Application, 2016 ($ Million)
2.3. Global Tamoxifen Market, by Geography, 2016 (Value %)
3. Global Tamoxifen Market Analysis
3.1. Global Tamoxifen Market Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.3. Attractive Investment Proposition, 2016
3.4. Competitive Landscape Assessment, By Key Market Players
4. Global Tamoxifen Market, By Application, 2015 – 2025 ($ Million)
4.2. Breast Cancer
4.3. McCune-Albright syndrome
4.5. Others (Infertility, Gene Expression, Riedel’s Thyroiditis)
5. Global Tamoxifen Market, By Application, 2015 – 2025 ($ Million)
5.1. Phase I
5.2. Phase II
5.3. Phase III
6. Global Tamoxifen Market, By Geography, 2015 – 2025 ($ Million)
6.2. North America
6.3.3. Rest of Europe
6.4. Asia Pacific
6.4.3. Rest of APAC
6.5. Latin America
6.6. Middle East and Africa
7. Company Profiles
7.1. AstraZeneca plc
7.1.1. Business Description
7.1.2. Financial Health and Budget Allocation
7.1.3. Product Positions/Portfolio
7.1.4. News Coverage
7.2. Allergan plc
7.3. Teva Pharmaceuticals Industries Ltd.
7.4. Apotex, Inc.
7.5. Mylan Pharmaceuticals, Inc.
7.6. Watson laboratories Inc.
7.7. Aegis pharmaceuticals Inc.
$ 4800/- Multi User License $ 6800/- Corporate License
- Markets in over 100+ countries analyzed granularly
- 35% of our total client are returning clients
- 1000+ customers globally
- 100+ paid data sources mined to bring cutting-edge insights
- 24x5 availability - we are always there when you need us
- "Free of Cost Report Customization" is available
- Request a regional report at Best Price
- Our expert team will assist you with all research need and customization
- Our expert research analysts will resolve your every query before and after purchasing the report